| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.009 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |